Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)

Ann Rheum Dis. 2015 Mar;74(3):627-30. doi: 10.1136/annrheumdis-2014-206695. Epub 2015 Jan 5.

Authors

Shunsuke Mori¹, Tamami Yoshitama², Toshihiko Hidaka³, Naoyuki Hirakata⁴, Yukitaka Ueki⁴

Affiliations

¹ Department of Rheumatology, Clinical Research Center for Rheumatic Diseases, NHO Kumamoto Saishunsou National Hospital, Kohshi, Kumamoto, Japan.
² Yoshitama Clinic for Rheumatic Diseases, Kirishima, Kagoshima, Japan.
³ Institute of Rheumatology, Zenjinkai Shimin-no-Mori Hospital, Miyazaki, Japan.
⁴ Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Nagasaki, Japan.

No abstract available

Keywords: Methotrexate; Outcomes research; Rheumatoid Arthritis; Treatment.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Female
Humans
Japan
Male
Middle Aged
Registries*
Renal Insufficiency, Chronic / complications*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
tocilizumab